972 filings
Page 27 of 49
8-K
ACER
Acer Therapeutics Inc.
9 Dec 14
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
10-Q
2014 Q3
ACER
Acer Therapeutics Inc.
Quarterly report
6 Nov 14
12:00am
8-K
ACER
Acer Therapeutics Inc.
6 Nov 14
Opexa Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
ACER
Acer Therapeutics Inc.
9 Oct 14
Regulation FD Disclosure
12:00am
8-K
ACER
Acer Therapeutics Inc.
16 Sep 14
Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock
12:00am
424B5
ACER
Acer Therapeutics Inc.
15 Sep 14
Prospectus supplement for primary offering
12:00am
8-K
ACER
Acer Therapeutics Inc.
15 Sep 14
Opexa Therapeutics, Inc. Announces Proposed
12:00am
8-K
ACER
Acer Therapeutics Inc.
8 Sep 14
Opexa Therapeutics to Target Rare Disease Neuromyelitis Optica (NMO) as next Development Program
12:00am
SC 13G/A
ACER
Acer Therapeutics Inc.
3 Sep 14
Opexa Therapeutics, Inc.
12:00am
10-Q
2014 Q2
ACER
Acer Therapeutics Inc.
Quarterly report
14 Aug 14
12:00am
8-K
ACER
Acer Therapeutics Inc.
14 Aug 14
Opexa Therapeutics Reports Second Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
ACER
Acer Therapeutics Inc.
25 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
ARS
2013 FY
ACER
Acer Therapeutics Inc.
16 May 14
Annual report to shareholders
12:00am
10-Q
2014 Q1
ACER
Acer Therapeutics Inc.
Quarterly report
14 May 14
12:00am
8-K
ACER
Acer Therapeutics Inc.
14 May 14
Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
ACER
Acer Therapeutics Inc.
13 May 14
Regulation FD Disclosure
12:00am
DEF 14A
ACER
Acer Therapeutics Inc.
Definitive proxy
12 May 14
12:00am
SC 13D/A
ACER
Acer Therapeutics Inc.
24 Apr 14
Opexa Therapeutics, Inc.
12:00am
8-K
ACER
Acer Therapeutics Inc.
24 Mar 14
Regulation FD Disclosure
12:00am
8-K
ACER
Acer Therapeutics Inc.
20 Mar 14
Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors
12:00am